References
- Baldassarre S, Vincent JL : Coagulopathy induced by Hydroxyethyl starch. Anesth Analg 84: 451-453, 1997 https://doi.org/10.1097/00000539-199702000-00040
- Hall ED : Efficacy and mechanisms of action of the cytoprotective lipid peroxidation inhibitor tirilazad mesylate in subarachnoid haemorrhage. Eur J Anaesth 13 : 279-289, 1996 https://doi.org/10.1097/00003643-199605000-00006
- Jamnicki M, Bombeli T, Seifert B, Zollinger A, Camenzind V, Pasch T, et al : Low-and Medium molecular-weight Hydroxyethyl starches. Anesthesiology 93 : 1231-1237, 2000 https://doi.org/10.1097/00000542-200011000-00016
- Kang SD : Prevention and Medical Management of Vasospasm. J Korean Neurosurg Soc 28: 1226-1231, 1999
- Kuitunen A, Hynynen M, Salmenpera M: Hydroxyethyl starch as a prime for cardiopulmonary bypass: effects of two different solutions on haemostasis. Acta Anaesthesiol Stand 37: 652-658, 1993 https://doi.org/10.1111/j.1399-6576.1993.tb03783.x
- Korosue K, Ishida K, Matsuoka H : Clinical hemodynamic and hemorheological effects of isovolemic hemodilution in acute cerebral infarction. Neurosurgery 23: 148-153, 1988 https://doi.org/10.1227/00006123-198808000-00003
- Korttila K, Grohn P, Gordin A : Effect of hydroxyethyl starch and dextran on plasma volume and blood hemostasis and coagulation. J Clin Pharmacol 24 : 273-282, 1984 https://doi.org/10.1002/j.1552-4604.1984.tb01833.x
- Kroemer H, Haass A, Muller K : Haemodilution therapy in ischaemic stroke: plasma concentrations and plasma viscosity during long-term infusion of dextran 40 or hydroxyethyl starch 200/0.5. Eur J Clin Pharmacol 31 : 705-710, 1987 https://doi.org/10.1007/BF00541299
- Levy ML, Giannotta SL : Cardiac performance indices during hypervolemic therapy for cerebral vasospasm. J Neurosurg 75 : 2731, 1991
- Mayberg MR, Batjer HH, Dacey R: Guidelines for the management of aneurysmal subarachnoid hemorrhage: a statement for healthcare professionals from a special writing group of the Stroke Council, American Heart Association. Stroke 25: 2315-2328, 1994 https://doi.org/10.1161/01.STR.25.11.2315
- Nearman HS, Herman ML: Toxic effects of colloids in the intensive care unit. Crit Care Clin 7: 713-723, 1991 https://doi.org/10.1016/S0749-0704(18)30302-6
- Perez-Trepichio AD, Furlan AJ, Little JR : Hydroxyethyl starch 200/0.5 reduces infarct volume after embolic stroke in rats. Stroke 23: 1782-1790, 1992 https://doi.org/10.1161/01.STR.23.12.1782
- Sanfelippo MJ, Suberviola PD : Development of a von Willebrand-like syndrome after prolonged use of hydroxyethyl starch. Am J Clin Pathol 43: 391-393, 1987
- Stoll M, Treib J, Schenk JF, Windisch F, Haass A, Wenzel E, et al: No coagulation disorders under high-dose volum therapy with lowmolecular-weight hydroxyethyl starch. Haemostasis 27 : 251-258, 1997
- Stump DC, Strauss RG, Henriksen RA : Effects of hydroxyethyl starch on blood coagulation, particularly factor VIII. Transfusion: 27-36, 2002
- Stump DC, Strauss RG, Henriksen RA, Patersen RE, Saunders R: A randomized, blinded trial comparing the hemostatic effects of pentastach versus hetastarch. Transfusion 25 : 349-354, 1985 https://doi.org/10.1046/j.1537-2995.1985.25485273815.x
- Treib J, Haass A, Pindur G : Coagulation disorders caused by Hydroxyethyl starch. Thromb Haemost 78: 974-983, 1997 https://doi.org/10.1055/s-0038-1657671
- Trumble ER, Muizelaar JP, Myseros JS : Coagulopathy with the use of hetastarch in the treatment of vasospasm. J Neurosurg 82 : 44-47, 1995 https://doi.org/10.3171/jns.1995.82.1.0044
- Vorstup S, Andersen A, Juhler M : Hemodilution increases cerebral blood flow in acute ischemic stroke. Stroke 20: 884-889, 1989 https://doi.org/10.1161/01.STR.20.7.884
- Weir B : Protection of the brain after aneurysmal rupture. Can J Neural Sci 22 : 177-186, 1995 https://doi.org/10.1017/S0317167100039810